Editorial: Testosterone deficiency syndrome (TDS) and the heart

European Heart Journal

Volumn 31, Issue 12, 2010, Pages 1436-1437

  Jackson, Graham ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TESTOSTERONE;

ANDROGEN DEFICIENCY; CARDIOVASCULAR RISK; COHORT ANALYSIS; COMORBIDITY; EDITORIAL; ERECTILE DYSFUNCTION; FOLLOW UP; GROUPS BY AGE; HEART; HUMAN; MORTALITY; OBSERVATIONAL STUDY; POPULATION; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; QUALITY OF LIFE; TESTOSTERONE BLOOD LEVEL; ADULT; AGED; HEART DISEASE; MALE; MIDDLE AGED; NOTE;

ADULT; AGED; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; TESTOSTERONE; YOUNG ADULT;

EID: 77953751778     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehq096     Document Type: Editorial

References (15)

1. Allan CA, McLachlan RI. Age-related changes in testosterone and the role of replacement therapy in older men. Clin Endocrinol (Oxf) 2004;60:653-670.
2. Traish AM, Saad F, Feeley RJ, Guay A. The dark side of testosterone deficiency: III. Cardiovascular disease. J Androl 2009;30:477-494.
3. Haring R, Völzke H, Steveling A, Krebs A, Felix SB, Schöfl C, Dörr M, Nauck M, Wallaschofski H. Low testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20-79. Eur Heart J 2010;31: 1494-1501. First published on 17 February 2010. doi:10.1093/eurheartj/ehq009.
4. Corona G, Monami M, Boddi V, Cameron-Smith M, Fisher AD, De Vita G, Melani C, Balzi D, Sforza A, Forti G, Mannucci E, Maggi M. Low testosterone is associated with increased risk of MACE lethality in subjects with erectile dysfunction. J Sex Med 2010;7:1557-1564.
5. Maggio M, Lauretani F, Ceda GP, Bandinelli S, Ling SM, Metter EJ, Artoni A, Carassale L, Cazzato A, Ceresini G, Guralnik JM, Basaria S, Valenti G, Ferrucci L. Relationship between low levels of anabolic hormones and 6-year mortality in older men: the aging in the Chianti Area (InCHIANTI) study. Arch Intern Med 2007;167:2249-2254.
6. Khaw KT, Dowsett M, Folkerd E, Bingham S, Wareham N, Luben R, Welch A, Day N. Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) prospective population study. Circulation 2007;116: 2694-2701.
7. Liu PY, Death AK, Handelsman DJ. Androgens and cardiovascular disease. Endocr Rev 2003;24:313-340.
8. Laughlin GA, Barrett-Connor E, Bergstrom J. Low serum testosterone and mortality in older men. J Clin Endocrinol Metab 2008;93:68-75.
9. Shores MM, Matsumoto AM, Sloan KL, Kivlahan DR. Low serum testosterone and mortality in male veterans. Arch Intern Med 2006;166:1660-1665.
10. Basaria S, Dobs AS. Testosterone making an entry into the cardiometabolic world. Circulation 2007;116:2658-2661.
11. Jackson G. Cardiovascular effects of testosterone. Curr Sex Health Rep 2008;5: 187-189.
12. Caminiti G, Volterrani M, Iellamo F, Marazzi G, Massaro R, Miceli M, Mammi C, Piepoli M, Fini M, Rosano GM. Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study. J Am Coll Cardiol 2009;54:919-927.
13. English KM, Steeds RP, Jones TH, Diver MJ, Channer KS. Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: a randomized, double-blind, placebo-controlled study. Circulation 2000; 102:1906-1911.
14. Miner M, Canty DJ, Shabsigh R. Testosterone replacement therapy in hypogona-dal men: assessing benefits, risks, and best practices. Postgrad Med 2008;120: 130-153.
15. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM. Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2006;91:1995-2010.